FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3156499789> ?p ?o ?g. }

• W3156499789 endingPage "1450" @default.
• W3156499789 startingPage "1435" @default.
• W3156499789 abstract "Background Cyanidin-3-O-glucoside (cyan) exhibits antioxidant and anticancer properties. The cell cycle proteins and antimitotic drugs might be promising therapeutic targets in hepatocellular carcinoma. Aim To investigate the effect of cyan administration on cell cycle in hepatic precancerous lesion (PCL) induced by diethylnitrosamine/2-acetylaminofluorene (DEN/2-AAF) in Wistar rats. Methods In vivo, DEN/2-AAF-induced hepatic PCL, rats were treated with three doses of cyan (10, 15, and 20 mg/kg/d, for four consecutive days per week for 16 wk). Blood and liver tissue samples were collected for measurement of the followings; alpha fetoprotein (AFP) liver function and RNA panel differential expression was evaluated via real time polymerase chain reaction. Histopathological examination of liver sections stained with H&E and immunohistochemical study using glutathione S-transferase placental (GSTP) and proliferating cell nuclear antigen (PCNA) antibodies were assessed. Results Cyan administration mitigated the effect of DEN/2-AFF induced PCL, decreased AFP levels, and improved liver function. Remarkably, treatment with cyan dose dependently decreased the long non-coding RNA MALAT1 and tubulin gamma 1 mRNA expressions and increased the levels of miR-125b, all of which are involved in cell cycle and mitotic spindle assembly. Of note, cyan decreased GSTP foci percent area and PCNA positively stained nuclei. Conclusion Our results indicated that cyan could be used as a potential therapeutic agent to inhibit liver carcinogenesis in rat model via modulation of cell cycle." @default.
• W3156499789 created "2021-04-26" @default.
• W3156499789 creator A5014603566 @default.
• W3156499789 creator A5016981834 @default.
• W3156499789 creator A5053957158 @default.
• W3156499789 creator A5060121521 @default.
• W3156499789 creator A5063132082 @default.
• W3156499789 creator A5085034244 @default.
• W3156499789 creator A5090677123 @default.
• W3156499789 date "2021-04-14" @default.
• W3156499789 modified "2023-09-26" @default.
• W3156499789 title "Cyanidin 3-glucoside modulated cell cycle progression in liver precancerous lesion, <i>in vivo</i> study" @default.
• W3156499789 cites W1431095005 @default.
• W3156499789 cites W1830256202 @default.
• W3156499789 cites W1859820530 @default.
• W3156499789 cites W1972436174 @default.
• W3156499789 cites W1982953422 @default.
• W3156499789 cites W2007015770 @default.
• W3156499789 cites W2007953117 @default.
• W3156499789 cites W2009756282 @default.
• W3156499789 cites W2016430576 @default.
• W3156499789 cites W2017463967 @default.
• W3156499789 cites W2020290693 @default.
• W3156499789 cites W2032950607 @default.
• W3156499789 cites W2035243232 @default.
• W3156499789 cites W2046387002 @default.
• W3156499789 cites W2047242157 @default.
• W3156499789 cites W2047275206 @default.
• W3156499789 cites W2053316950 @default.
• W3156499789 cites W2058970225 @default.
• W3156499789 cites W2060772907 @default.
• W3156499789 cites W2068182875 @default.
• W3156499789 cites W2068517905 @default.
• W3156499789 cites W2073003808 @default.
• W3156499789 cites W2073962613 @default.
• W3156499789 cites W2074203079 @default.
• W3156499789 cites W2078114178 @default.
• W3156499789 cites W2078358000 @default.
• W3156499789 cites W2103098475 @default.
• W3156499789 cites W2105349784 @default.
• W3156499789 cites W2107685513 @default.
• W3156499789 cites W2113174175 @default.
• W3156499789 cites W2116168949 @default.
• W3156499789 cites W2118562565 @default.
• W3156499789 cites W2123820544 @default.
• W3156499789 cites W2125102375 @default.
• W3156499789 cites W2128619556 @default.
• W3156499789 cites W2134435289 @default.
• W3156499789 cites W2141337702 @default.
• W3156499789 cites W2148629421 @default.
• W3156499789 cites W2158387229 @default.
• W3156499789 cites W2158549280 @default.
• W3156499789 cites W2169416332 @default.
• W3156499789 cites W2175928272 @default.
• W3156499789 cites W2233319040 @default.
• W3156499789 cites W2311541448 @default.
• W3156499789 cites W2340695018 @default.
• W3156499789 cites W2487276109 @default.
• W3156499789 cites W2611236857 @default.
• W3156499789 cites W2618584271 @default.
• W3156499789 cites W2761652902 @default.
• W3156499789 cites W2763496293 @default.
• W3156499789 cites W2765801252 @default.
• W3156499789 cites W2791607881 @default.
• W3156499789 cites W2800668305 @default.
• W3156499789 cites W2835792371 @default.
• W3156499789 cites W2890478343 @default.
• W3156499789 cites W2897297745 @default.
• W3156499789 cites W2898314774 @default.
• W3156499789 cites W2902908338 @default.
• W3156499789 cites W2909849443 @default.
• W3156499789 cites W2948389648 @default.
• W3156499789 cites W2964282552 @default.
• W3156499789 cites W2965740555 @default.
• W3156499789 cites W2967173832 @default.
• W3156499789 cites W2986189315 @default.
• W3156499789 cites W3090870670 @default.
• W3156499789 cites W4234850301 @default.
• W3156499789 doi "https://doi.org/10.3748/wjg.v27.i14.1435" @default.
• W3156499789 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8047539" @default.
• W3156499789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33911466" @default.
• W3156499789 hasPublicationYear "2021" @default.
• W3156499789 type Work @default.
• W3156499789 sameAs 3156499789 @default.
• W3156499789 citedByCount "7" @default.
• W3156499789 countsByYear W31564997892022 @default.
• W3156499789 countsByYear W31564997892023 @default.
• W3156499789 crossrefType "journal-article" @default.
• W3156499789 hasAuthorship W3156499789A5014603566 @default.
• W3156499789 hasAuthorship W3156499789A5016981834 @default.
• W3156499789 hasAuthorship W3156499789A5053957158 @default.
• W3156499789 hasAuthorship W3156499789A5060121521 @default.
• W3156499789 hasAuthorship W3156499789A5063132082 @default.
• W3156499789 hasAuthorship W3156499789A5085034244 @default.
• W3156499789 hasAuthorship W3156499789A5090677123 @default.
• W3156499789 hasBestOaLocation W31564997891 @default.
• W3156499789 hasConcept C121608353 @default.
• W3156499789 hasConcept C126322002 @default.

• next